CURI vs NXST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CURI

35.2
AI Score
VS
NXST Wins

NXST

36.0
AI Score

Investment Advisor Scores

CURI

35score
Recommendation
AVOID NEW MONEY

NXST

36score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI NXST Winner
Forward P/E 8.0645 10.0908 CURI
PEG Ratio 0 0.3204 Tie
Revenue Growth 22.3% 78.0% NXST
Earnings Growth 1400.0% 270.1% CURI
Tradestie Score 35.2/100 36.0/100 NXST
Profit Margin 0.0% 5.5% NXST
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED NXST

Relative Price Performance (Last 90 Days)

CURI 1M: -13.9% · 3M: -13.9% NXST 1M: +28.7% · 3M: +11.6%

Current Technical Phase

CURI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.0%), weak momentum, RSI 35

RSI (14): 35.2 · Price: $2.41

NXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 84

RSI (14): 83.6 · Price: $206.59

Fundamentals Snapshot

Metric CURI NXST
Market Cap — —
Forward P/E 7.8 9.0
Trailing P/E — 18.2
Revenue (TTM) — —
Revenue Growth 0.2% 0.8%
Gross Margin 0.6% 0.6%
Operating Margin 0.4% 0.3%
EPS 0.00 11.05
Dividend Yield 0.13% 0.04%

Frequently Asked Questions

Based on our detailed analysis, NXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.